ReviewFocus on mTOR inhibitors and tacrolimus in renal transplantation: Pharmacokinetics, exposure–response relationships, and clinical outcomes☆
Under a Creative Commons license
open access
Keywords
mTOR inhibitors
Calcineurin inhibitors
Tacrolimus
Renal transplantation
Pharmacokinetics
Therapeutic drug monitoring
Cited by (0)
- ☆
Conflicts of interest: F Shihab has served as a speaker for Novartis and as a consultant for Novartis and Astellas. U Christians has received research support from Novartis. J Wellen has served as a speaker for Novartis and Bristol Myers Squibb. B Kaplan has received research support from Bristol Myers Squibb. L Smith has nothing to disclose.
Copyright © 2014 The Authors. Published by Elsevier B.V.